Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease

Дата публикации: 03-09-2026 00:00:00

The TEASE-1 randomized clinical trial evaluates the safety and efficacy of oral gildeuretinol acetate on the growth of retinal atrophic lesions in individuals with Stargardt disease.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	rTG ω-3 Fatty Acids in Dry Eye Disease With MGD	0	8	01-07-2024
2	Highly Aspherical Lenslets for Myopia Control	0	6.82	20-08-2026
3	Ultra–Long-Distance Robotic-Assisted Subretinal Injection for Submacular Hemorrhage	0	16.79	20-08-2026
4	Digital Defocus Vision Training Using Virtual Reality for Myopia Control	0	9.14	27-08-2026
5	Event-Based Progression Detection Among OCT, OCTA, and VF in Glaucoma	0	9.28	03-09-2026
6	Empagliflozin and the Risk of Retinopathy in Type 2 Diabetes	0	11.22	01-01-2025
7	Time-Varying Effects of Valacyclovir Prophylaxis in the Zoster Eye Disease Study	0	8.29	01-09-2026
8	Dry Eye Disease Therapies at a Crossroads	0	6.4	17-09-2026
9	HOTV Vision Test Compared With Tumbling E for Pediatric Vision Screening	0	4.86	27-08-2026
10	Support, Educate, Empower Program and Medication Adherence	0	4.95	01-04-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 3.79. Источник: jamanetwork.com.